California State Court Judge: Incretin Mimetic Pancreatic Cancer Claims Preempted

(November 30, 2015, 8:43 AM EST) -- LOS ANGELES — Following the lead of a federal multidistrict litigation judge, a California state court judge on Nov. 13 granted summary judgment against about 287 plaintiffs who claim that incretin mimetic diabetes drugs caused pancreatic cancer (In Re: Byetta Cases, No. JCCP 4574, Calif. Super., Los Angeles Co.).

(Byetta opinion available. Document #28-151203-014Z.)

Judge William F. Highberger of the Los Angeles County Superior Court, who is presiding over the Judicial Council Coordinated Proceeding (JCCP) for the drugs, said that the question of federal preemption of...
To view the full article, register now.